Artificial Vision, Anti-VEGFs Focus of EURETINA Congress

by Medscape • 2016/09/02 • 0 Comments

Artificial vision, anti-VEGF therapies, and interactive sessions with thought leaders discussing the latest studies are planned for the European Society of Retina Specialists 16th EURETINA Congress.
Medscape Medical News

Full Story →

← Global Safety Goggles and Glasses Market Growth of 3.66% CAGR by 2020 – Analysis, Technologies & Forecasts Report 2016-2020 – Key Vendors: Radians, Sellstrom, MCR Safety – Research and Markets

Cataract Surgery after a Vitrectomy →

Post navigation